Used as a chiral intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structure supports the development of selective receptor modulators due to its stereochemical purity and ability to influence binding affinity. Commonly employed in the preparation of kinase inhibitors and neuroactive agents where the (R)-enantiomer provides enhanced potency and reduced off-target effects. Also utilized in asymmetric synthesis routes to improve yield and enantioselectivity in drug manufacturing processes.